Patricia K. Welch
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Chemokine receptors and signaling, Asthma and respiratory diseases, Chemical Synthesis and Analysis, Antimicrobial Peptides and Activities, Receptor Mechanisms and Signaling
Most-Cited Works
- → Discovery of CC Chemokine Receptor-3 (CCR3) Antagonists with Picomolar Potency(2005)62 cited
- → Discovery and Structure−Activity Relationship of N-(Ureidoalkyl)-Benzyl-Piperidines As Potent Small Molecule CC Chemokine Receptor-3 (CCR3) Antagonists(2002)48 cited
- → CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure–activity relationships(2002)46 cited
- → Nutrition Education, Body Composition, and Dietary Intake of Female College Athletes(1987)37 cited
- → From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: The discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis(2007)30 cited
- → Position of the American Dietetic Association(2002)24 cited
- → N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists(2004)18 cited
- → CC chemokine receptor-3 (CCR3) antagonists: Improving the selectivity of DPC168 by reducing central ring lipophilicity(2007)16 cited
- → 2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: Synthesis and selectivity(2006)15 cited
- → From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part II: Acyclic replacements for the (3S)-3-benzylpiperidine in a series of potent CCR3 antagonists(2007)11 cited